FilingReader Intelligence
Huaxi Bio controlling shareholder plans 200-300m yuan buyback
August 7, 2025 at 01:50 PM UTC•By FilingReader AI
Huaxi Bio's controlling shareholder Huaxi Xinyu Investment will buy 200-300 million yuan of shares within six months via Shanghai Stock Exchange.
Purchases will be made at prices not exceeding 70 yuan per share and will not trigger a tender offer.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:688363•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Bloomage Biotechnology Corporation publishes news
Free account required • Unsubscribe anytime